Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 22, 2026

Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders
SynGas Fuel Saver Claims Evaluated: Efficient Fuel Consumption OBD2 Device to Save Money on Gas
The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering
Corporate Update

Corporate Update

Perseus Reports Strong Operational Performance
Racent Showcases sslTrus CLM at GOPS 2026, Highlighting Automated Certificate Management
AI Agents Just Got Employee Badges: Developer Launches First Work Platform Where Agents Are Full Users
Clearfield Sets Fiscal Second Quarter 2026 Earnings Call for Wednesday, May 6, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Communiqué de presse :  Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
 nCino Announces Nick Edwards as Managing Director for APAC
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
AI GPU Rental Launches New AI-Driven Supercomputing to Simplify Bitcoin Passive Earnings
Hammond Power Solutions Announces First Quarter 2026 Financial Results Conference Call and Webcast Notification
Canfor releases 2025 Sustainability Report
Blue Jay Gold Corp. Appoints Colin Healey to Board Of Directors
Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026
Eseye strengthens global IoT resilience with SGP.32 eSIM orchestration
CEMATRIX to Report First Quarter 2026 Results on April 29, 2026
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.